Emily A Hemann1, Jodi L McGill, Kevin L Legge. 1. Department of Pathology and Interdisciplinary Graduate Program in Immunology, University of Iowa, Iowa City, Iowa.
Abstract
BACKGROUND: It is well established that chronic ethanol (EtOH) consumption is associated with increased incidence and disease severity of respiratory infections. Our recent work demonstrates this increase in disease severity to influenza A virus (IAV) infections is due, in part, to a failure to mount a robust IAV-specific CD8 T cell response along with a specific impairment in the ability of these T cells to produce interferon γ (IFNγ). However, the full extent of the lesion in the effector CD8 T cell compartment during chronic EtOH consumption remains unknown. METHODS: Utilizing the Meadows-Cook murine model of chronic alcohol consumption, mice received EtOH in their drinking water for 8 or 12 weeks. Mice were challenged intranasally with IAV, and the activation and effector functions of IAV-specific CD8 T cells were determined in both the lung-draining lymph nodes (dLN) and lungs. RESULTS: Our results confirm the defect in IFNγ production; however, the ability of IAV-specific T cells to produce tumor necrosis factor α (TNFα) and interleukin-2 (IL-2) in EtOH-consuming mice remains unaltered. In contrast, EtOH consumption significantly reduces the ability of CD8 T cells to degranulate and kill IAV-specific targets. Finally, our findings suggest the lesion begins during the initial activation of CD8 T cells, as we observe early defects in proliferation in the dLN of IAV-infected, EtOH-consuming mice. CONCLUSIONS: These findings highlight the previously unrecognized depth of the lesion in the IAV-specific CD8 T cell response during chronic EtOH consumption. Given the important role CD8 T cell immunity plays in control of IAV, these findings may aid in the development of vaccination and/or therapeutic strategies to reverse these defects in the CD8 T cell response and reduce serious disease outcomes associated with IAV infections in alcoholics.
BACKGROUND: It is well established that chronic ethanol (EtOH) consumption is associated with increased incidence and disease severity of respiratory infections. Our recent work demonstrates this increase in disease severity to influenza A virus (IAV) infections is due, in part, to a failure to mount a robust IAV-specific CD8 T cell response along with a specific impairment in the ability of these T cells to produce interferon γ (IFNγ). However, the full extent of the lesion in the effector CD8 T cell compartment during chronic EtOH consumption remains unknown. METHODS: Utilizing the Meadows-Cook murine model of chronic alcohol consumption, mice received EtOH in their drinking water for 8 or 12 weeks. Mice were challenged intranasally with IAV, and the activation and effector functions of IAV-specific CD8 T cells were determined in both the lung-draining lymph nodes (dLN) and lungs. RESULTS: Our results confirm the defect in IFNγ production; however, the ability of IAV-specific T cells to produce tumornecrosis factor α (TNFα) and interleukin-2 (IL-2) in EtOH-consuming mice remains unaltered. In contrast, EtOH consumption significantly reduces the ability of CD8 T cells to degranulate and kill IAV-specific targets. Finally, our findings suggest the lesion begins during the initial activation of CD8 T cells, as we observe early defects in proliferation in the dLN of IAV-infected, EtOH-consuming mice. CONCLUSIONS: These findings highlight the previously unrecognized depth of the lesion in the IAV-specific CD8 T cell response during chronic EtOH consumption. Given the important role CD8 T cell immunity plays in control of IAV, these findings may aid in the development of vaccination and/or therapeutic strategies to reverse these defects in the CD8 T cell response and reduce serious disease outcomes associated with IAV infections in alcoholics.
Authors: Erik L Brincks; Prajwal Gurung; Ryan A Langlois; Emily A Hemann; Kevin L Legge; Thomas S Griffith Journal: J Immunol Date: 2011-09-21 Impact factor: 5.422
Authors: Ji Fan; Michelle R Edsen-Moore; Lucas E Turner; Robert T Cook; Kevin L Legge; Thomas J Waldschmidt; Annette J Schlueter Journal: Alcohol Clin Exp Res Date: 2010-10-06 Impact factor: 3.455
Authors: Matthew G Thompson; Flor Navarro; Lennox Chitsike; Luis Ramirez; Elizabeth J Kovacs; Stephanie K Watkins Journal: Alcohol Date: 2016-10-18 Impact factor: 2.405
Authors: José Luis Zaldivar Fujigaki; América Guadalupe Arroyo Valerio; Juan Carlos López Alvarenga; Esperanza Gabriela Gutiérrez Reyes; David Kershenobich; Joselin Hernández Ruiz Journal: PLoS One Date: 2015-07-07 Impact factor: 3.240
Authors: Lindsay M Margoles; Rohit Mittal; Nathan J Klingensmith; John D Lyons; Zhe Liang; Mara A Serbanescu; Maylene E Wagener; Craig M Coopersmith; Mandy L Ford Journal: PLoS One Date: 2016-11-18 Impact factor: 3.240
Authors: Xiude Fan; Zhengwen Liu; Kyle L Poulsen; Xiaoqin Wu; Tatsunori Miyata; Srinivasan Dasarathy; Daniel M Rotroff; Laura E Nagy Journal: Nutrients Date: 2021-05-10 Impact factor: 5.717
Authors: Todd A Wyatt; Kristi J Warren; Tanner J Wetzel; Troy Suwondo; Gage P Rensch; Jane M DeVasure; Deanna D Mosley; Kusum K Kharbanda; Geoffrey M Thiele; Ellen L Burnham; Kristina L Bailey; Samantha M Yeligar Journal: Am J Pathol Date: 2021-06-27 Impact factor: 5.770
Authors: Xiude Fan; Zhengwen Liu; Kyle L Poulsen; Xiaoqin Wu; Tatsunori Miyata; Srinivasan Dasarathy; Daniel M Rotroff; Laura E Nagy Journal: medRxiv Date: 2020-11-30